RMND5A expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.08690834110803E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.7745000000513E-06 |
Normal-vs-Stage2 |
1.02300000004441E-06 |
Normal-vs-Stage3 |
1.11022302462516E-16 |
Normal-vs-Stage4 |
1.62547753035369E-12 |
Stage1-vs-Stage2 |
4.896500E-02 |
Stage1-vs-Stage3 |
2.70280000003176E-06 |
Stage1-vs-Stage4 |
8.70559999976983E-07 |
Stage2-vs-Stage3 |
2.830600E-01 |
Stage2-vs-Stage4 |
1.261780E-01 |
Stage3-vs-Stage4 |
4.743800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.93525228964609E-13 |
Normal-vs-AfricanAmerican |
3.16529999988546E-08 |
Normal-vs-Asian |
1.557570E-01 |
Caucasian-vs-AfricanAmerican |
1.846640E-01 |
Caucasian-vs-Asian |
8.488000E-01 |
AfricanAmerican-vs-Asian |
4.846000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62680979798324E-12 |
Normal-vs-Female |
3.008700000251E-07 |
Male-vs-Female |
7.519700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.578300E-04 |
Normal-vs-Age(41-60Yrs) |
1.29080002242432E-09 |
Normal-vs-Age(61-80Yrs) |
2.07578398914166E-12 |
Normal-vs-Age(81-100Yrs) |
5.25389998173864E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.211400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.805400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.704600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.249800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.299900E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.767830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.757200E-01 |
Normal-vs-Grade 2 |
2.978000E-04 |
Normal-vs-Grade 3 |
<1E-12 |
Normal-vs-Grade 4 |
1.62436730732907E-12 |
Grade 1-vs-Grade 2 |
3.227200E-01 |
Grade 1-vs-Grade 3 |
3.434300E-04 |
Grade 1-vs-Grade 4 |
1.20660000002548E-06 |
Grade 2-vs-Grade 3 |
8.06290000321397E-08 |
Grade 2-vs-Grade 4 |
4.20086188057667E-12 |
Grade 3-vs-Grade 4 |
1.460100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.607950E-02 |
Normal-vs-ccB subtype |
1.62447832963153E-12 |
ccA subtype-vs-ccB subtype |
1.76636483217862E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.60116405981626E-12 |
Normal-vs-N1 |
3.38689998269359E-09 |
N0-vs-N1 |
9.072100E-02 |
|
|